Next Century Growth Investors LLC Aerie Pharmaceuticals Inc Transaction History

Next Century Growth Investors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $4.42 Million - $7.35 Million	-152,441 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$36.32 - $49.25 $677,259 - $918,364	-18,647 Reduced 10.9%	152,441 $7.24 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $818,103 - $1.49 Million	24,791 Added 16.95%	171,088 $6.18 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $8.21 Million - $10.8 Million	146,297 New	146,297 $9 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $3.54 Million - $5.21 Million	-73,979 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$51.15 - $61.0 $949,548 - $1.13 Million	-18,564 Reduced 20.06%	73,979 $4.01 Million
Q4 2017 Feb 13, 2018	SELL	$50.85 - $65.1 $424,292 - $543,194	-8,344 Reduced 8.27%	92,543 $5.53 Million
Q3 2017 Nov 14, 2017	SELL	$48.6 - $60.1 $1.81 Million - $2.24 Million	-37,197 Reduced 26.94%	100,887 $4.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	138,084	138,084 $7.26 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.